Age‐ and Gender‐Related Use of Low‐Dose Drug Therapy: The Need to Manufacture Low‐Dose Therapy and Evaluate the Minimum Effective Dose

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-5415|47|8|954-959

ISSN： 0002-8614

Source： JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol.47, Iss.8, 1999-08, pp. : 954-959

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low‐Dose Intravenous Immunoglobulin Therapy for Intractable Dermatomyositis Skin Lesions

By  

THE JOURNAL OF DERMATOLOGY, Vol. 26, Iss. 7, 1999-07 ,pp. : 457-459

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral Anticoagulant Therapy: Efficacy, Safety and the Low-Dose Controversy

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 2-3, 2000-01 ,pp. : 150-165

Karger

Access to resources Recommend Favorite

Combination Therapy with Low‐Dose Etretinate and Eicosapentaenoic Acid for Psoriasis Vulgaris

By  

THE JOURNAL OF DERMATOLOGY, Vol. 25, Iss. 11, 1998-11 ,pp. : 703-705

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Low-Dose Spironolactone Therapy Is Safe in Oligoanuric Hemodialysis Patients

By  

Cardiology, Vol. 114, Iss. 1, 2009-04 ,pp. : 32-38

Karger

Access to resources Recommend Favorite

Is There a Role for Low-Dose Eltrombopag as Maintenance Therapy in the Treatment of Immune Thrombocytopenia?

By  

Acta Haematologica, Vol. 133, Iss. 1, 2014-08 ,pp. : 78-82

Karger

Access to resources Recommend Favorite